Your browser doesn't support javascript.
loading
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma.
Thanendrarajan, Sharmilan; Tian, Erming; Qu, Pingping; Mathur, Pankaj; Schinke, Carolina; van Rhee, Frits; Zangari, Maurizio; Rasche, Leo; Weinhold, Niels; Alapat, Daisy; Bellamy, William; Ashby, Cody; Mattox, Sandra; Epstein, Joshua; Yaccoby, Shmuel; Barlogie, Bart; Hoering, Antje; Bauer, Michael; Walker, Brian A; Davies, Faith E; Morgan, Gareth J.
Affiliation
  • Thanendrarajan S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Tian E; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Qu P; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Mathur P; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Schinke C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • van Rhee F; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zangari M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Rasche L; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Alapat D; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Bellamy W; Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Ashby C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Mattox S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Epstein J; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Yaccoby S; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Hoering A; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Bauer M; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Walker BA; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Davies FE; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA gjmorgan@uams.edu.
Haematologica ; 102(9): e364-e367, 2017 09.
Article in En | MEDLINE | ID: mdl-28550191
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 17 / Tumor Suppressor Protein p53 / Chromosome Deletion / Multiple Myeloma Limits: Aged / Aged80 / Humans Language: En Journal: Haematologica Year: 2017 Document type: Article Affiliation country: United States Country of publication: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chromosomes, Human, Pair 17 / Tumor Suppressor Protein p53 / Chromosome Deletion / Multiple Myeloma Limits: Aged / Aged80 / Humans Language: En Journal: Haematologica Year: 2017 Document type: Article Affiliation country: United States Country of publication: Italy